HU1300063D0 - Tisztított hCG - Google Patents

Tisztított hCG

Info

Publication number
HU1300063D0
HU1300063D0 HUP1300063A HU1300063D0 HU 1300063 D0 HU1300063 D0 HU 1300063D0 HU P1300063 A HUP1300063 A HU P1300063A HU 1300063 D0 HU1300063 D0 HU 1300063D0
Authority
HU
Hungary
Prior art keywords
hcg
purification
ion
exchange chromatography
purified hcg
Prior art date
Application number
Other languages
English (en)
Inventor
Gianfranco Paradisi
Mara Rossi
Laura Scaglia
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of HU1300063D0 publication Critical patent/HU1300063D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUP1300063 2000-02-22 2001-01-22 Tisztított hCG HU1300063D0 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
HU0204231A HU228935B1 (en) 2000-02-22 2001-01-22 Process of purification of hcg and recombinant hcg purified by that method
PCT/EP2001/000665 WO2001062773A1 (en) 2000-02-22 2001-01-22 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD

Publications (1)

Publication Number Publication Date
HU1300063D0 true HU1300063D0 (hu) 2003-03-28

Family

ID=8167925

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0204231A HU228935B1 (en) 2000-02-22 2001-01-22 Process of purification of hcg and recombinant hcg purified by that method
HUP1300063 HU1300063D0 (hu) 2000-02-22 2001-01-22 Tisztított hCG

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0204231A HU228935B1 (en) 2000-02-22 2001-01-22 Process of purification of hcg and recombinant hcg purified by that method

Country Status (32)

Country Link
US (2) US7297777B2 (hu)
EP (2) EP1257564B1 (hu)
JP (1) JP4588960B2 (hu)
KR (1) KR100806911B1 (hu)
CN (1) CN100482679C (hu)
AT (1) ATE406378T1 (hu)
AU (2) AU783320B2 (hu)
BG (1) BG65807B1 (hu)
BR (1) BRPI0108556B8 (hu)
CA (1) CA2399020A1 (hu)
CY (1) CY1108460T1 (hu)
CZ (1) CZ303144B6 (hu)
DE (1) DE60135541D1 (hu)
DK (1) DK1257564T3 (hu)
EA (1) EA006605B1 (hu)
EE (1) EE05644B1 (hu)
ES (1) ES2307585T3 (hu)
HK (1) HK1052016A1 (hu)
HR (1) HRP20020650B1 (hu)
HU (2) HU228935B1 (hu)
IL (2) IL151308A0 (hu)
ME (1) ME00296B (hu)
MX (1) MXPA02007871A (hu)
NO (1) NO328694B1 (hu)
PL (1) PL205149B1 (hu)
PT (1) PT1257564E (hu)
RS (1) RS50741B (hu)
SI (1) SI1257564T1 (hu)
SK (1) SK287146B6 (hu)
UA (2) UA86938C2 (hu)
WO (1) WO2001062773A1 (hu)
ZA (1) ZA200206109B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00296B (me) * 2000-02-22 2011-05-10 Applied Res Systems Ars Holding N V PROCES PREČIŠĆAVANJA hCG I REKOMBINANTNOG hCG PREČIŠĆENOG TOM METODOM
EP1709065B1 (en) * 2004-10-04 2010-06-02 Novetide Ltd. A counterion exchange process for peptides
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
WO2008007993A1 (fr) * 2006-07-11 2008-01-17 Koval, Anton Alexandrovich Utilisation d'une hormone chorionique ou lutéinisante destinée à la prévention ou au traitement de l'hypogonadisme lié à l'âge
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜***的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
JP6087338B2 (ja) 2011-03-31 2017-03-01 フェリング ベスローテン フェンノートシャップ 医薬製剤
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种***的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜***的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜***冻干粉针剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE148171T1 (de) * 1989-02-21 1997-02-15 Univ Washington Modifizierte formen von fortpflanzungshormonen
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) * 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
UA61053C2 (en) 1995-03-21 2003-11-17 Applied Research Systems Stable liquid pharmaceutical compositions, method for its production and delivery form
US6193972B1 (en) * 1996-02-20 2001-02-27 Applied Research Systems Ars Holding N.V. Hybrid heterodimeric protein hormone
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
AU8142198A (en) 1997-06-12 1998-12-30 Regents Of The University Of California, The A transcription factor coactivator protein, p/cip
CA2289665C (en) * 1997-06-13 2005-08-09 Genentech, Inc. Protein recovery by chromatography followed by filtration upon a charged layer
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
ME00296B (me) * 2000-02-22 2011-05-10 Applied Res Systems Ars Holding N V PROCES PREČIŠĆAVANJA hCG I REKOMBINANTNOG hCG PREČIŠĆENOG TOM METODOM

Also Published As

Publication number Publication date
CA2399020A1 (en) 2001-08-30
CN1404485A (zh) 2003-03-19
BR0108556A (pt) 2003-01-28
PL357508A1 (en) 2004-07-26
NO20023985L (no) 2002-08-21
EP1257564A1 (en) 2002-11-20
EE05644B1 (et) 2013-04-15
JP4588960B2 (ja) 2010-12-01
EE200200469A (et) 2004-04-15
BG65807B1 (bg) 2009-12-31
HU228935B1 (en) 2013-06-28
ZA200206109B (en) 2003-07-31
EA006605B1 (ru) 2006-02-24
AU2680401A (en) 2001-09-03
SK12062002A3 (sk) 2002-12-03
US20030104553A1 (en) 2003-06-05
HUP0204231A3 (en) 2005-09-28
MEP38908A (en) 2011-02-10
KR20030001359A (ko) 2003-01-06
UA78488C2 (en) 2007-04-10
CN100482679C (zh) 2009-04-29
CZ20022855A3 (cs) 2002-11-13
IL151308A0 (en) 2003-04-10
DK1257564T3 (da) 2008-10-06
SK287146B6 (sk) 2010-01-07
NO20023985D0 (no) 2002-08-21
HRP20020650A2 (en) 2004-12-31
HK1052016A1 (en) 2003-08-29
EA200200892A1 (ru) 2003-02-27
AU2006200059A1 (en) 2006-02-02
IL151308A (en) 2009-11-18
RS50741B (sr) 2010-08-31
ME00296B (me) 2011-05-10
CY1108460T1 (el) 2014-04-09
ES2307585T3 (es) 2008-12-01
CZ303144B6 (cs) 2012-05-02
ATE406378T1 (de) 2008-09-15
US7297777B2 (en) 2007-11-20
UA86938C2 (uk) 2009-06-10
EP1752466A3 (en) 2012-10-10
PT1257564E (pt) 2008-09-10
WO2001062773A1 (en) 2001-08-30
US20070299001A1 (en) 2007-12-27
MXPA02007871A (es) 2003-02-10
BRPI0108556B8 (pt) 2021-05-25
JP2003524015A (ja) 2003-08-12
YU60202A (sh) 2005-09-19
DE60135541D1 (de) 2008-10-09
HRP20020650B1 (en) 2011-02-28
HUP0204231A2 (hu) 2003-03-28
AU783320B2 (en) 2005-10-13
PL205149B1 (pl) 2010-03-31
BG107000A (en) 2003-04-30
EP1752466A2 (en) 2007-02-14
BRPI0108556B1 (pt) 2015-04-14
EP1257564B1 (en) 2008-08-27
KR100806911B1 (ko) 2008-02-22
SI1257564T1 (sl) 2008-12-31
NO328694B1 (no) 2010-04-26

Similar Documents

Publication Publication Date Title
HK1052016A1 (en) Process of purification of hcg
HK1052014A1 (en) Purified lh
EP0769554A3 (en) Human CNP gene and precursor protein
EP0868920A3 (en) Hybrid protein for treatment of bladder cancer cells
WO2002018443A3 (en) A recombinant monoclonal antibody to phosphotyrosine-containing proteins
CA2462232A1 (en) Method for reconstituting a recombinant protein to its biologically active form
van Herwijnen et al. Verzeichnis der Benutzten Editionen
IT1219554B (it) Trattamento dell' infertilita'

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished